Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: A case control study

Lancet

Volumn 358, Issue 9284, 2001, Pages 791-795

  Bista, Mahendra Bahadur ^a   Banerjee, M K ^a   Shin, Sun Heang ^b   Tandan, J B ^c   Kim, Myung Ho ^c   Sohn, Young Mo ^d   Ohrr, Hee Choul ^d   Tang, Jin Ling ^e   Halstead, Scott B ^f  

^a Minister for Health and Population Nepal   (Nepal)

^b Glovax Co Ltd   (South Korea)

^c School of Health Sciences   (Nepal)

^d Yonsei University   (South Korea)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; SA 14142;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFICACY; EPIDEMIC ENCEPHALITIS; EXPOSURE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; NEPAL; PRIORITY JOURNAL;

EID: 0035828397     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05967-0     Document Type: Article

References (23)

1. Japanese encephalitis vaccines
2. New initiatives for the control of Japanese encephalitis by vaccination
3. Dengue (with notes on yellow fever and Japanese encephalitis)
4. The epidemiology of Japanese encephalitis: Prospects for prevention
5. Protection against Japanese encephalitis by inactivated vaccines
6. Japanese encephalitis: Inactivated Japanese encephalitis virus vaccine
7. Adverse events after Japanese encephalitis vaccination: Review of post-marketing surveillance data from Japan and the United States
8. Selection of a better immunogenic and highly attenuated live vaccine strain of Japanese encephalitis II: Safety and immunogenicity of live JBE vaccine SA 14-14-2 observed in inoculated children
9. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA 14-14-2) for children
10. Observations on safety and serological efficacy from a large-scale field trial of Japanese encephalitis vaccine
11. Short-term safety of live-attenuated Japanese encephalitis vaccine (SA14-14-2): Results of a randomized trial with 26,239 subjects
12. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14-14-2): A case-control study
13. Primary and booster immune responses to SA 14-14-2 Japanese encephalitis vaccine in Korean infants
14. Immunogenicity of live attenuated SA 14-14-2 Japanese encephalitis vaccine - A comparison of 1- and 3-month immunization schedules
15. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate
16. Field evaluation of vaccine efficacy
17. Use of the case-control approaches in vaccine evaluation: Efficacy and adverse effects
18. Exact inference for matched case-control studies
19. The exposure odds ratio in nested case control studies with competing risks
20. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children